MIQBX | VTPSX | MIQBX / VTPSX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 29 years | 14 years | - |
Gain YTD | 5.029 | 6.077 | 83% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 100000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 675M | 443B | 0% |
Annual Yield % from dividends | 0.29 | 3.30 | 9% |
Returns for 1 year | 7.38 | 8.83 | 84% |
Returns for 3 years | -0.76 | 1.10 | -69% |
Returns for 5 years | 2.46 | 14.02 | 18% |
Returns for 10 years | -1.27 | 35.83 | -4% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
LYFIX | 12.93 | 0.02 | +0.15% |
AlphaCentric Life Sciences & Hlthcare I | |||
TIOVX | 15.24 | N/A | N/A |
Nuveen International Opps W | |||
FRRSX | 17.33 | -0.06 | -0.35% |
Franklin Real Estate Securities C | |||
RRMVX | 31.68 | -0.21 | -0.66% |
T. Rowe Price Mid-Cap Value R | |||
BSMKX | 17.51 | -0.20 | -1.13% |
iShares Russell Small/Mid-Cap Idx K |